EUVIMED · CrossrefZeitschrift
Molecular Therapy Nucleic Acids
ISSN 2162-2531 · Elsevier BV
Neueste Artikel
Emerging strategies and innovations in circular RNA synthesis
Precision therapeutics for early onset epilepsy: Allele-selective antisense oligonucleotides for SCN2A-related epilepsy
Nucleoside-modified circRNA: Reduced immunogenicity and expansive applications beyond vaccines
Nascent chain folding feeds back on mRNA stability through the ribosome: Consequences for therapeutic mRNA design
Blocking two host receptors is better than one: Insights from RSV infection in human respiratory organoids
From codon optimization to AI-guided sequence design for engineered biological functions
Opportunities to enhance protections for individualized interventions involving gene-editing
Engineering microRNAs as multimodal cancer therapeutics
Gene therapy for hereditary hematological disorders: From clinical breakthroughs to future horizons
Novel lipid nanoparticle in a mRNA cancer vaccine drives tumor control via type I IFNs and effector CD8+ T cells
Functional analysis of TTN uORFs reveals context-dependent translational regulation
Human T cell engineering via serial delivery of mRNA encapsulated within lipid nanoparticles
Codon-dependent translation of N1-ethylpseudouridine-modified mRNA reduces innate immunity while preserving vaccine immunogenicity
An mRNA-lipid nanoparticle vaccine targeting the Plasmodium vivax E140 antigen
Cas12a chRDNA-mediated in vivo genome editing for high specificity functional gene disruption
2026: A watershed year for RNA therapeutics—From breakthrough vaccines to chronic indications and beyond
siRNA did not fail in cancer. It was given the wrong job
Myogenic differentiation-derived small extracellular vesicles as a therapeutic strategy for miR-193b-3p-mediated muscle regeneration
Distinct responses of COL17A1 nonsense variants to readthrough drugs and NOG as a novel enhancer in junctional epidermolysis bullosa
Integrated in vitro transcription and oligo-dT affinity chromatography enable multi-cycle reagent recycling for mRNA manufacturing
Segmented poly(A) tails with microRNA target sites confer tissue-specific regulation for mRNA therapeutics
Governing at speed? China’s hard question in need of soft solutions
Rebuilding a protective allele with ADAR site-directed RNA editing
Bridging the antiviral gap: A BAC-based non-infectious SARS-CoV-2 replicon reveals potent antisense gapmers
Single-cell and intercellular communication analyses reveal DLL3 as a key regulator in the glioma tumor microenvironment
Roles of meiotic and mitotic cohesin in stem cell gene regulation and genome stability
rAAV-mediated multi-miRNA delivery targeting MAPK pathway suppresses laser-induced choroidal neovascularization in mice
RNA-encoded PGT121-LS anti-HIV antibody: Comprehensive preclinical characterization and translational pharmacokinetics
Aptamer-guided delivery of miR-126 suppresses glioblastoma stem-like cell invasion and tumor progression
Combination of live-attenuated and adenovirus-based vaccines provides immediate and durable protection against Yersinia pestis in mice
EUVIMED